Myoclonus.
Myoclonus in childhood may be a primary condition, or it may be associated with a number of identifiable conditions. Successful therapy is dependent on diagnosis of underlying conditions and subsequent choice of appropriate drugs.
Swaiman
K F
KF
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002998:Clonazepam / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004569:Electroencephalography; D004831:Epilepsies, Myoclonic / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009207:Myoclonus / Q000145:classification*; D009567:Nitrazepam / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013036:Spasms, Infantile / Q000175:diagnosis / Q000628:therapy; D014635:Valproic Acid / Q000627:therapeutic use
D002998:Clonazepam; D014635:Valproic Acid; D000324:Adrenocorticotropic Hormone; D009567:Nitrazepam; D011241:Prednisone